PHEN Walk 2015 Call-to-Action Platform

 

Review, in a public forum, the scientific evidence and process used by the U. S. Preventive Services Task Force for its Grade "D" prostate cancer screening recommendation which is adversely impacting the early detection of prostate cancer.

Increase the budget for prostate cancer research at The Department of Defense's Congressionally Directed Medical Research Program (CDMRP) to equal the budget for breast cancer research. The increased amount should be allocated for research towards the populations at highest risk for prostate cancer: African American men, men with a family history of the disease and veterans exposed to Agent Orange. Funding for the Centers for Disease Control's (CDC) prostate cancer activities should be maintained and increased. 

Light the White House blue during prostate cancer awareness month (September) as it is lighted pink for breast cancer awareness month (October). Professional sports teams should promote prostate cancer awareness to their audiences and employees in the same manner that they promote breast cancer awareness.

Put into action the intent of U. S. Senate Resolution "S. Res 529" passed in 2012 recognizing prostate cancer to be a crisis of epidemic proportion among African American men.  

Accelerate insurance coverage for the new class of prostate cancer tests that have proven to help determine prostate cancer risks, and the most appropriate course of treatment for patients.

Maintain patient access to medical benefits for reconstructive prosthetic urological procedures utilizing medical devices to treat incontinence and impotence. Continued access to these restorative procedures is critical to the quality of life for prostate cancer patients. 
 

 

CALL TO ACTION BACKGROUND INFORMATION


Join the PHEN Walk 2015 Competition




PHEN Walk 
Home



PHEN,Inc. © 2019 All rights reserved